Loading...
OTCM
VBACY
Market cap3.48bUSD
, Last price  
USD
Name

Virbac SA

Chart & Performance

D1W1MN
OTCM:VBACY chart
P/E
—
P/S
—
EPS
17.35
Div Yield, %
—
Shrs. gr., 5y
-0.13%
Rev. gr., 5y
8.29%
Revenues
1.40b
+12.07%
372,403,000401,636,000438,548,000443,355,000467,418,000572,830,000623,059,000695,155,000736,080,000773,116,000852,623,000871,828,000861,882,000868,932,000938,342,000934,198,0001,063,964,9991,216,187,0001,246,901,0001,397,380,000
Net income
145m
+19.78%
19,799,00024,913,00031,873,00036,287,00039,676,00064,313,00058,555,00066,625,00060,523,00063,596,0009,405,00034,646,000-2,575,00020,099,00051,550,000136,039,000113,162,000121,967,000121,298,000145,290,000
CFO
204m
+71.68%
35,764,00048,807,00050,451,00042,280,00064,778,00083,897,00061,781,00097,033,00073,633,00076,447,00046,221,000142,449,000107,806,00083,623,000131,609,000110,221,000126,292,00098,984,000118,957,000204,221,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
URL
https://corporate.virbac.com/
IPO date
Jan 01, 1985
Employees
5,386
Domiciled in
FR
Incorporated in
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT